Indenebart clinical trials
Also written TAK-341 and MEDI1341.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses indenebart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses indenebart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of TAK-341 in Treatment of Multiple System AtrophyCompletedPhase 2TakedaNCT05526391Written as TAK-341
- Single Ascending Dose Study of MEDI1341 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT03272165Written as MEDI1341
- Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's DiseaseCompletedPhase 1AstraZenecaNCT04449484Written as MEDI1341
Codes
What other systems call indenebart · ClinicalTrials.gg INT014518
- UNII (FDA) 2RIB5BB8CXINDENEBARTOne source FDA
- NCI Thesaurus C206924IndenebartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2RIB5BB8CX | INDENEBART | One source FDA |
| NCI Thesaurus | C206924 | Indenebart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.